Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/70799
DC FieldValueLanguage
dc.contributor.authorLim, P.S.en_US
dc.contributor.authorCheng, Y.M.en_US
dc.contributor.authorYang, S.M.en_US
dc.date2007zh_TW
dc.date.accessioned2014-06-11T06:00:22Z-
dc.date.available2014-06-11T06:00:22Z-
dc.identifier.issn1320-5358zh_TW
dc.identifier.urihttp://hdl.handle.net/11455/70799-
dc.description.abstractBackground: End-stage renal disease (ESRD) is associated with enhanced oxidative stress and may contribute to substantial cardiovascular complications in dialysis patients. Recent studies suggested that human serum albumin (HSA), the major plasma protein, may possess a direct vasculoprotective antioxidant effect. In this study, we investigated if such protective effect is impaired in uremic milieu. Methods: Thirty-one ESRD patients on maintenance haemodialysis and 22 age-matched healthy controls were recruited. Serum albumin was purified and changes in biological properties of HSA were analysed by several biochemistry techniques, spectrophotometric measurements, ligand-binding assays and western blot analysis. Results: We found that both dityrosine (0.25 +/- 0.1 vs 0.15 +/- 0.07, P < 0.001), and carbonyl (10.5 +/- 1.88 nmol/mg vs 5.29 +/- 1.21 nmol/mg, P < 0.001) contents were increased in the uremic HSA. Decreased thiol activity of plasma was also noted and may be related to dimerization of HSA. In addition, uremic HSA had shown impaired ligand-binding capability such as haemin (0.37 x 10(7)/M vs 2.18 x 10(7)/M, P < 0.001), bilirubin (0.08 x 10(6)/M vs 0.15 x 10(6)/M, P < 0.05) and cis-parinaric acid (3.8 x 10(7)/M vs 2.9 x 10(7)/M, P < 0.05). Furthermore, using two different systems namely copper mediated oxidation of human low density lipoproteins and the free radicals mediated haemolysis test, we have demonstrated that the observed changes of uremic HSA can affect its antioxidant properties. Conclusion: In conclusion, the present study demonstrated that the quality and integrity of HSA molecule in dialysis patients were subtly altered and impaired its biological properties. Oxidative alterations of this major plasma protein might adversely affect its vasculoprotective effects in dialysis patients.en_US
dc.language.isoen_USzh_TW
dc.relationNephrologyen_US
dc.relation.ispartofseriesNephrology, Volume 12, Issue 1, Page(s) 18-24.en_US
dc.relation.urihttp://dx.doi.org/10.1111/j.1440-1797.2006.00745.xen_US
dc.subjectend-stage renal diseaseen_US
dc.subjecthaemolysisen_US
dc.subjectLDL peroxidationen_US
dc.subjectligand-bindingen_US
dc.subjectcapabilityen_US
dc.subjectprotein carbonylen_US
dc.subjectlow-density-lipoproteinen_US
dc.subjectcoronary-heart-diseaseen_US
dc.subjectchronic-renal-failureen_US
dc.subjectc-reactive proteinen_US
dc.subjectcardiovascular-diseaseen_US
dc.subjectoxidative stressen_US
dc.subjectfree-radicalsen_US
dc.subjectmortalityen_US
dc.subjectplasmaen_US
dc.subjecthypoalbuminemiaen_US
dc.titleImpairments of the biological properties of serum albumin in patients on haemodialysisen_US
dc.typeJournal Articlezh_TW
dc.identifier.doi10.1111/j.1440-1797.2006.00745.xzh_TW
Appears in Collections:期刊論文
文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.